Cyclooxygenase-2 inhibitors: a new therapeutic option in the treatment of macular edema after cataract surgery.

Autor: Reis A; Reis Medical Institution, Principality of Liechtenstein, Germany. reis@augenwerk.li, Birnbaum F, Hansen LL, Reinhard T
Jazyk: angličtina
Zdroj: Journal of cataract and refractive surgery [J Cataract Refract Surg] 2005 Jul; Vol. 31 (7), pp. 1437-40.
DOI: 10.1016/j.jcrs.2004.12.067
Abstrakt: Two patients had uneventful phacoemulsification. After initial improvement, vision deteriorated because of cystoid macular edema (CME). In 1 patient, treatment with systemic nonsteroidal antiinflammatory drugs showed significant improvement in visual acuity but had to be discontinued because of side effects and a relapse of the disease. In the other patient, this therapy was not sufficient. Both patients were given valdecoxib, a cyclooxygenase-2 inhibitor. The new therapy was tolerated well and led to significant and stable improvement in visual acuity in both patients. To our knowledge, this is the first report of using a cyclooxygenase-2 inhibitor in the treatment of clinically significant CME.
Databáze: MEDLINE